Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (191-200 of 610) with videos related to

Pageof 61
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2011
Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in IranPeyman Eshghi, Nader Cohan, Manigeh Lak, et al.
Journal of Clinical Medicine|February 25, 2023
Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet NeedsGiancarlo Castaman, Flora Peyvandi, Raimondo De Cristofaro, et al.
Thrombosis Research|August 8, 2013
Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal statusFranca Franchi, Eugenia Biguzzi, Ida Martinelli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 19, 2023
Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standardBarbara A Konkle, Flora Peyvandi, Donna Coffin, et al.
Transfusion|August 6, 2022
Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA-02 and FORMA-04 clinical trialsClaudia Djambas Khayat, Sunil Lohade, Omid Reza Zekavat, et al.
Seminars in Thrombosis and Hemostasis|June 19, 2018
Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand SyndromeFrancesca Stufano, Marco Boscarino, Paolo Bucciarelli, et al.
Haematologica|September 28, 2019
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpuraSilvia Riva, Ilaria Mancini, Alberto Maino, et al.
American Journal of Preventive Medicine|November 22, 2011
Knowledge and therapeutic gaps: a public health problem in the rare coagulation disorders populationAmy D Shapiro, J Michael Soucie, Flora Peyvandi, et al.
Thrombosis and Haemostasis|January 12, 2013
Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathiesIan Mackie, Katy Langley, Andrew Chitolie, et al.
Haematologica|March 30, 2019
Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacementElena Santagostino, Maria Elisa Mancuso, Cristina Novembrino, et al.
Pageof 61

Showing results (191-200 of 610) with videos related to

Sort By:
Pageof 61
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2011
Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in IranPeyman Eshghi, Nader Cohan, Manigeh Lak, et al.
Journal of Clinical Medicine|February 25, 2023
Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet NeedsGiancarlo Castaman, Flora Peyvandi, Raimondo De Cristofaro, et al.
Thrombosis Research|August 8, 2013
Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal statusFranca Franchi, Eugenia Biguzzi, Ida Martinelli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 19, 2023
Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standardBarbara A Konkle, Flora Peyvandi, Donna Coffin, et al.
Transfusion|August 6, 2022
Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA-02 and FORMA-04 clinical trialsClaudia Djambas Khayat, Sunil Lohade, Omid Reza Zekavat, et al.
Seminars in Thrombosis and Hemostasis|June 19, 2018
Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand SyndromeFrancesca Stufano, Marco Boscarino, Paolo Bucciarelli, et al.
Haematologica|September 28, 2019
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpuraSilvia Riva, Ilaria Mancini, Alberto Maino, et al.
American Journal of Preventive Medicine|November 22, 2011
Knowledge and therapeutic gaps: a public health problem in the rare coagulation disorders populationAmy D Shapiro, J Michael Soucie, Flora Peyvandi, et al.
Thrombosis and Haemostasis|January 12, 2013
Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathiesIan Mackie, Katy Langley, Andrew Chitolie, et al.
Haematologica|March 30, 2019
Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacementElena Santagostino, Maria Elisa Mancuso, Cristina Novembrino, et al.
Pageof 61